In CLL cells, the constitutive activation of STAT-3 and NF-κB causes the delivery of IL-6, which further increases JAK2/STAT3 stimulation, leading to the IL-6/JAK/STAT3 feed-forward loop that controls tumor proliferation [25]. The gene discussed is STAT3; the disease is neoplasm.